Use of polymerase chain reaction in human African trypanosomiasis stage determination and follow-up.
Stage determination of human African trypanosomiasis is based on the detection of parasites and measurements of biological changes in the cerebrospinal fluid (CSF) (concentration of white blood cells > 5 cells per mm3 and increased total protein levels). The patient is treated accordingly. Demonstration of the absence or presence of trypanosomes by the double centrifugation technique is still the only test available to clinicians for assessing treatment success. In this study, however, we evaluate the polymerase chain reaction (PCR) as a tool for assessing the disease stage of trypanosomiasis and for determining whether treatment has been successful. All 15 study patients considered to be in the advanced stage of the disease were PCR positive; however, trypanosomes were demonstrated by double centrifugation in only 11 patients. Of the five remaining patients, who were considered to be in the early stage, PCR and double centrifugation were negative. Following treatment, 13 of the 15 second-stage patients were found to be negative for the disease in at least two samples by PCR and double centrifugation. Two others were still positive by PCR immediately and one month after the treatment. Trypanosome DNA detection using PCR suggested that the two positive patients were not cured but that their possible relapse could not be identified by a search for parasites using the double centrifugation technique. Further evaluation of the PCR method is required, in particular to determine whether PCR assays could be used in studies on patients who fail to respond to melarsoprol, as observed in several foci.
Truc
P
P
Institut de Recherche pour le Développement, Montpellier, France.
Jamonneau
V
V
Cuny
G
G
Frézil
J L
JL
D000818:Animals; D002498:Centrifugation; D016054:DNA, Protozoan / Q000032:analysis; D005500:Follow-Up Studies; D006801:Humans; D008549:Melarsoprol / Q000627:therapeutic use; D016133:Polymerase Chain Reaction; D013997:Time Factors; D014344:Trypanocidal Agents / Q000627:therapeutic use; D014345:Trypanosoma / Q000235:genetics; D014353:Trypanosomiasis, African / Q000175:diagnosis* / Q000188:drug therapy
D016054:DNA, Protozoan; D014344:Trypanocidal Agents; D008549:Melarsoprol